Atrial fibrillation: will new drugs and patient choice improve anticoagulation outcomes?
- PMID: 15772185
- PMCID: PMC1768851
- DOI: 10.1136/hrt.2004.047902
Atrial fibrillation: will new drugs and patient choice improve anticoagulation outcomes?
Abstract
The growing epidemic of atrial fibrillation presents major challenges to the healthcare community, both clinical and financial.
Comment on
-
Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population.Heart. 2005 Apr;91(4):472-7. doi: 10.1136/hrt.2004.042465. Heart. 2005. PMID: 15772203 Free PMC article.
Similar articles
-
Direct thrombin inhibition: a novel approach to stroke prevention in patients with atrial fibrillation.Stroke. 2004 Jun;35(6):1519-22. doi: 10.1161/01.STR.0000128883.89984.52. Epub 2004 May 13. Stroke. 2004. PMID: 15143301 No abstract available.
-
Ximelagatran or warfarin for stroke prevention in patients with atrial fibrillation?Stroke. 2004 Feb;35(2):389-91. doi: 10.1161/01.STR.0000115528.53718.1B. Stroke. 2004. PMID: 14757889 Clinical Trial. No abstract available.
-
Trials of newer approaches to anticoagulation in atrial fibrillation.J Interv Card Electrophysiol. 2004;10 Suppl 1:27-31. doi: 10.1023/B:JICE.0000011343.08424.d9. J Interv Card Electrophysiol. 2004. PMID: 14739737 Review.
-
Direct thrombin inhibitors: stroke prevention in atrial fibrillation and potential anti-inflammatory properties.Am Heart J. 2005 Jan;149(1 Suppl):S32-5. doi: 10.1016/j.ahj.2004.10.020. Am Heart J. 2005. PMID: 15644791 Review. No abstract available.
-
Prevention of stroke in patients with atrial fibrillation.Semin Vasc Med. 2005 Aug;5(3):285-92. doi: 10.1055/s-2005-916168. Semin Vasc Med. 2005. PMID: 16123916 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical